EVOLUS, INC. Increase (Decrease) in Other Operating Assets
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Other Operating Assets of $5.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-05
- EVOLUS, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $1.94M, a 40.58% increase year-over-year.
- EVOLUS, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $3.87M, a 123.43% increase year-over-year.
- EVOLUS, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $240.00K.
- EVOLUS, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$884.00K, a 312.50% decline year-over-year.
- EVOLUS, INC. increase (decrease) in other operating assets for fiscal 2025 was $2.47M.
- EVOLUS, INC. increase (decrease) in other operating assets for fiscal 2024 was -$706.00K, a 181.71% decline from fiscal 2023.
- EVOLUS, INC. increase (decrease) in other operating assets for fiscal 2023 was $864.00K.
- EVOLUS, INC. increase (decrease) in other operating assets for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.81M 10-Q · filed 2026-08-05 | $6.05M derived: sum of 3 quarters · filed 2026-08-05 | $5.17M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $3.87M 10-Q · filed 2026-05-04 | $4.11M derived: sum of 2 quarters · filed 2026-05-04 | $3.23M derived: sum of 3 quarters · filed 2026-05-04 | $4.61M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$644.00K derived: sum of 2 quarters · filed 2026-03-03 | $736.00K derived: sum of 3 quarters · filed 2026-08-05 | $2.47M 10-K · filed 2026-03-03 | |
| 2025-09-30 | -$884.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $496.00K derived: sum of 2 quarters · filed 2026-08-05 | $2.23M 10-Q · filed 2025-11-05 | $1.04M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.11M 10-Q · filed 2026-08-05 | $1.92M derived: sum of 3 quarters · filed 2026-08-05 | $2.34M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $1.73M 10-Q · filed 2026-05-04 | $541.00K derived: sum of 2 quarters · filed 2026-05-04 | $957.00K derived: sum of 3 quarters · filed 2026-05-04 | ||
| 2024-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$776.00K derived: sum of 2 quarters · filed 2026-03-03 | -$706.00K 10-K · filed 2026-03-03 | ||
| 2024-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $486.00K 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $70.00K 10-Q · filed 2025-08-05 | ||||
| 2023-12-31 | $974.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $941.00K derived: sum of 2 quarters · filed 2026-03-03 | $952.00K derived: sum of 3 quarters · filed 2026-03-03 | $864.00K 10-K · filed 2026-03-03 | |
| 2023-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$22.00K derived: sum of 2 quarters · filed 2023-11-07 | -$110.00K 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$77.00K 10-Q · filed 2023-08-02 | |||
| 2023-03-31 | -$88.00K 10-Q · filed 2023-05-09 | ||||
| 2022-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.15M derived: sum of 2 quarters · filed 2023-11-07 | -$2.30M 10-Q · filed 2023-11-07 | -$2.30M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$945.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$4.40M 10-Q · filed 2023-08-02 | -$4.40M derived: sum of 3 quarters · filed 2023-08-02 | -$10.68M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | -$3.45M 10-Q · filed 2023-05-09 | -$3.45M derived: sum of 2 quarters · filed 2023-05-09 | -$9.74M derived: sum of 3 quarters · filed 2023-05-09 | -$5.11M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$6.28M derived: sum of 2 quarters · filed 2022-11-08 | -$1.66M derived: sum of 3 quarters · filed 2022-11-08 | $0.00 10-K · filed 2022-03-03 | |
| 2021-09-30 | -$6.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.66M derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$201.00K derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $6.28M 10-Q · filed 2022-08-02 | $6.08M derived: sum of 3 quarters · filed 2022-08-02 | $4.98M derived: sum of 4 quarters · filed 2022-08-02 | |
| 2021-03-31 | $1.66M 10-Q · filed 2022-05-10 | $1.46M derived: sum of 2 quarters · filed 2022-05-10 | $351.00K derived: sum of 3 quarters · filed 2022-05-10 | $146.00K derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$1.31M derived: sum of 2 quarters · filed 2022-03-03 | -$1.51M derived: sum of 3 quarters · filed 2022-03-03 | -$1.50M 10-K · filed 2022-03-03 | |
| 2020-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$1.31M derived: sum of 2 quarters · filed 2021-11-02 | -$1.30M 10-Q · filed 2021-11-02 | -$1.34M derived: sum of 4 quarters · filed 2021-11-02 | |
| 2020-06-30 | -$205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$191.00K 10-Q · filed 2021-08-04 | -$239.00K derived: sum of 3 quarters · filed 2021-08-04 | -$1.00K derived: sum of 4 quarters · filed 2021-08-04 | |
| 2020-03-31 | $14.00K 10-Q · filed 2021-05-12 | -$93.00K 10-Q · filed 2020-05-11 | -$34.00K derived: sum of 2 quarters · filed 2021-05-12 | $204.00K derived: sum of 3 quarters · filed 2021-05-12 | $204.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $190.00K derived: sum of 2 quarters · filed 2021-03-25 | $190.00K derived: sum of 3 quarters · filed 2021-03-25 | $190.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $238.00K derived: sum of 2 quarters · filed 2020-10-29 | $238.00K 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $211.00K 10-K · filed 2020-02-25 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |